CTOs on the Move

InterGanics

www.interganics.com

 
InterGanics is a global solution-driven company that supports ingredients and finish products manufacturers to design an environmentally safe, socially responsible and economically sustainable sourcing strategy around Organic, Non-GMO and Specialty products.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Cesca Therapeutics

We are at the cutting-edge of medical development – and through our advanced clinical trials, novel medical device development and in-house cellular manufacturing and quality control expertise, we intend to lead the industry. We are uniquely positioned and expect to maintain our leadership position though active collaborations with physicians, researchers, hospitals and blood banks on a wide range of clinical, cell-based approaches to medical treatment.

Specialty Carts

Specialty Carts is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vizer

Vizer is an exercise rewards app that allows you to donate meals and earn points towards rewards at local businesses. Learn more and get started today!

Hci Medical

Hci Medical is a Conrad, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.